Synthego Gets PTAB To Review 2 Full CRISPR Patents
The Patent Trial and Appeal Board has agreed to review whether two Agilent Technologies Inc. patents related to the breakthrough gene-editing technology CRISPR should be invalidated....To view the full article, register now.
Already a subscriber? Click here to view full article